These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22234921)

  • 21. The influence of contrast media on kidney function in patients with stable coronary artery disease.
    Reuter SB; Harutyunyan M; Mygind ND; Jørgensen E; Kastrup J
    Scand Cardiovasc J; 2014 Aug; 48(4):234-40. PubMed ID: 24941300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
    Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
    Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
    Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
    Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
    Möckel M; Radovic M; Kühnle Y; Combé V; Waigand J; Schröder S; Dietz R; Frei U; Eckardt KU
    Nephrol Dial Transplant; 2008 May; 23(5):1588-94. PubMed ID: 18175785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical impact of nephropathy induced by contrast medium in patients with acute myocardial infarction undergoing emergent coronary angiography].
    Jujo K; Yamaguchi J; Obayashi K; Suzuki K; Sekiguchi H; Nagashima M; Tsurumi Y; Kasanuki H
    J Cardiol; 2006 Jul; 48(1):9-16. PubMed ID: 16886495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
    Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN
    J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
    Shin DH; Choi DJ; Youn TJ; Yoon CH; Suh JW; Kim KI; Cho YS; Cho GY; Chae IH; Kim CH
    Am J Cardiol; 2011 Jul; 108(2):189-94. PubMed ID: 21545991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-induced nephropathy in urgent coronary interventions.
    Valente S; Lazzeri C; Giglioli C; Margheri M; Comeglio M; Nicolaci L; Chechi T; Gensini GF
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):737-41. PubMed ID: 17001234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk factors of contrast-induced nephropathy in patients with myocardial infarction].
    Kalaeva VV; Karetnikova VN; Osokina AV; Gruzdeva OV; Kashtalap VV; Evseeva MV; Bykova IS; Zykov MV; Shafranskaia KS; Barbarash OL
    Klin Med (Mosk); 2014; 92(9):39-45. PubMed ID: 25790710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
    Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk score for the prediction of contrast-induced nephropathy in elderly patients undergoing percutaneous coronary intervention.
    Fu N; Li X; Yang S; Chen Y; Li Q; Jin D; Cong H
    Angiology; 2013 Apr; 64(3):188-94. PubMed ID: 23196639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions.
    Wróbel W; Sinkiewicz W; Gordon M; Woźniak-Wiśniewska A
    Kardiol Pol; 2010 Sep; 68(9):1015-20. PubMed ID: 20859892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.
    Liu Y; Tan N; Zhou YL; Chen YY; Chen JY; Chen J; Luo JF
    J Nephrol; 2012; 25(3):332-40. PubMed ID: 21928234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
    Schönefeld E; Höwler S; Osada N; Torsello G
    Zentralbl Chir; 2011 Oct; 136(5):426-30. PubMed ID: 22009540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Elbasan Z; Şahin DY; Gür M; Kuloğlu O; Kivrak A; Içen YK; Türkoglu C; Yildirim A; Özdogru I; Çayli M
    Angiology; 2014 Jan; 65(1):37-42. PubMed ID: 23109331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
    Chong E; Shen L; Poh KK; Tan HC
    Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diastolic dysfunction predicts the risk of contrast-induced nephropathy and outcome post-emergency percutaneous coronary intervention in AMI patients with preserved ejection fraction.
    Han B; Li Y; Dong Z; Wan Q; Shen H; Li J; Wei M; Shen C
    Heart Vessels; 2018 Oct; 33(10):1149-1158. PubMed ID: 29704102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can contrast-induced nephropathy after percutaneous coronary intervention be accurately predicted with a risk score?
    Marenzi G
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):80-1. PubMed ID: 16265376
    [No Abstract]   [Full Text] [Related]  

  • 39. Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention.
    Nozue T; Michishita I; Iwaki T; Mizuguchi I; Miura M
    J Cardiol; 2009 Oct; 54(2):214-20. PubMed ID: 19782258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. As the kidney goes, so goes the heart….
    Hundal HS; Cigarroa JE
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):886-7. PubMed ID: 24395723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.